Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Direct cell killing by suicide genes

L A Martin1, N R Lemoine

  • 1ICRF Oncology Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

Cancer Metastasis Reviews
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mercury isotope constraints on artisanal and small-scale gold mining source contributions and redox cycling in the Yanomami Indigenous Territory.

Journal of hazardous materials·2025
Same author

Pancreatic Cancer UK Grand Challenge: Developments and challenges for effective CAR T cell therapy for pancreatic ductal adenocarcinoma.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2020
Same author

ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation.

Oncogene·2016
Same author

Immune-checkpoint blockade: the springboard for immuno-combination therapy.

Gene therapy·2015
Same author

Ecological Genetics and Host Range Expansion by Busseola fusca (Lepidoptera: Noctuidae).

Environmental entomology·2015
Same author

Lister strain vaccinia virus with thymidine kinase gene deletion is a tractable platform for development of a new generation of oncolytic virus.

Gene therapy·2015
Same journal

Metastasis as a breakdown of the multicellular social contract.

Cancer metastasis reviews·2026
Same journal

HER2 assessment in urothelial carcinoma: standardization challenges and the path forward.

Cancer metastasis reviews·2026
Same journal

Resolving translational challenges in cancer biology through yeast experimental evolution.

Cancer metastasis reviews·2026
Same journal

Spheroids and organoids to study long noncoding RNAs in cancer: how they could replace animal models.

Cancer metastasis reviews·2026
Same journal

Strategies and successes of smoking cessation methods in head and neck cancer patients: a systematic review.

Cancer metastasis reviews·2026
Same journal

The Hippo signaling pathway in pediatric brain tumors: molecular mechanisms and therapeutic opportunities.

Cancer metastasis reviews·2026
See all related articles

Genetic interventions can induce cell death through prodrug therapies, toxin gene expression, or apoptotic triggers. This review examines targeting strategies and the current status of clinical trials for these cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Genetic interventions offer diverse strategies for inducing targeted cell death.
  • Prodrug activation therapies, toxin gene expression, and apoptotic triggers are key approaches.

Purpose of the Study:

  • To review genetic strategies for inducing cell death.
  • To examine targeting mechanisms for genetic interventions.
  • To assess the current clinical trial landscape for these therapies.

Main Methods:

  • Literature review of genetic prodrug activation therapies (mammalian and non-mammalian enzymes).
  • Review of toxin gene expression and apoptotic trigger systems.
  • Analysis of targeting strategies including transductional restriction and transcriptional control.

Related Experiment Videos

  • Examination of in vitro and in vivo study systems.
  • Review of current clinical trial data.

    • Main Results:

    • Multiple genetic methods exist for inducing cell death, including prodrug activation and direct expression of cell death-inducing agents.
    • Targeting can be achieved through both genetic and cellular control mechanisms.
    • In vitro and in vivo studies demonstrate the feasibility of these approaches.
    • Clinical trials are underway, indicating progress towards therapeutic application.

    Conclusions:

    • Genetic interventions represent a promising avenue for cancer therapy by inducing targeted cell death.
    • Effective targeting strategies are crucial for maximizing efficacy and minimizing off-target effects.
    • Ongoing clinical trials will determine the ultimate clinical utility of these genetic approaches.